NK cells are innate immune cells and have important roles in antiviral and antitumor immunity. Based on the transcriptional regulation, organ distribution, and cell function, NK cells have recently been further divided into cytotoxic conventional NK cells (cNK) and noncytotoxic helper-like group 1 innate lymphoid cells (ILC1s). It is well known that chronic alcohol consumption decreases peripheral NK cell number and cytolytic activity; however, the underlying mechanism remains to be elucidated. How chronic alcohol consumption affects ILC1s is, to our knowledge, completely unexplored. Herein, we used a well-established mouse model of chronic alcohol consumption to study the effects of alcohol on transcription factor expression, maturation, and cytokine production of cNK cells and ILC1s in various organs. We found that alcohol consumption significantly decreased Eomes-expressing cNK cells in all the examined organs, except BM, but did not significantly affect ILC1s. Alcohol consumption compromised cNK cell development and maturation. Exogenous IL-15/IL-15Ra treatment caused full recovery of Eomes-expressing cNK cell number and maturation. Taken together, our data indicated that chronic alcohol consumption decreases cNK cell number and cytolytic activity by arresting cNK cell development at the CD27 + CD11b + stage. This developmental arrest of NK cells results from a lack of IL-15 availability in the microenvironment. IL-15/IL-15Ra treatment can recover alcohol consumption-induced developmental defect in NK cells.
Introduction
NK cells are innate lymphocytes and have important roles in antiviral and antitumor immunity. These cells were defined as CD3 2 NK1.1 + in mice and CD3 2 CD56 + in humans [1, 2] . Most NK cells (.90%) are generated in BM and distribute into peripheral lymphoid organs, such as the spleen and LNs, and into nonlymphoid organs, such as the liver and lung. One of the most important functional characteristics of NK cells is the direct killing of target cells without prior sensitization. NK cells were recognized as the sole innate lymphocytes since they were identified in the 1970s. This notion has changed upon finding ILCs, which are abundant on mucosal surfaces [3] . Based on transcriptional determination and cytokine production, ILCs are divided into 3 groups: ILC1s, ILC2s, and ILC3s [4] [5] [6] . These 3 groups of ILCs are parallel to their respective Th cells-Th1, Th2, and Th17-in cytokine production and transcriptional determination [7] . ILC1s are T-bet-dependent and produce Th1 cytokines, such as IFN-g [8] ; ILC2s are GATA3 dependent and produce Th2 cytokines, such as IL-4, IL-5, and IL-13, among others [9] . ILC3s are RORgt dependent and primarily produce the IL-17 family cytokines [10, 11] . NK cells were initially classified as group 1 ILCs because they share the same phenotype of CD3 2 NK1.1 + and produce Th1 hallmark cytokine IFN-g. Recent studies on cell fate-mapping and cell functional analysis have distinguished NK cells from group 1 ILCs [12] . The 2 major differences between NK cells and group 1 ILCs include: 1) transcription factor Eomes is essential for NK cell development and maturation; however, Eomes does not express in group 1 ILCs; and 2) NK cells produce not only the Th1 cytokine IFN-g but also perforin and granzymes, whereas group 1 ILCs produce only Th1 cytokines and do not produce perforin and produce only low levels of granzymes [12, 13] . Therefore, NK cells are cytotoxic, and group 1 ILCs are noncytotoxic [14] . The + [16] . Most ILC1s express CD127, the a chain of the IL-7 receptor [12] . Therefore, ILC1s have the same phenotype as thymus-derived NK cells. Eomes can be used to distinguish bona fide, thymus-derived NK cells (Eomes . These cells were considered the immature form or precursor of liver-resident NK cells [17] . Recent studies have indicated that these cells are Eomes 2 and cannot mature further into Eomes + NK cells [18] . Therefore, these cells are ILC1s. It is well known that chronic alcohol consumption decreases the number and cytolytic activity of NK cells in the peripheral blood of human alcoholics [19] [20] [21] . Using a mouse model of chronic alcohol consumption, we and others also found that alcohol consumption significantly decreases the number and cytolytic activity of NK cells in the spleen, liver, and LNs; impairs NK cell release from BM; and compromises NK cell development and maturation [22] [23] [24] [25] . IL-15/IL-15Ra treatment can normalize NK cell numbers [26] . However, all these studies defined NK cells as CD3 2 NK1.1 + and did not distinguish NK cells from ILC1s. In addition, it is not known whether IL-15/IL15Ra treatment could restore NK cell development and maturation. To address these issues, we conducted the present study and found that chronic alcohol consumption compromises cNK cells by inhibiting Eomes expression. IL-15/IL-15Ra treatment not only recovers cNK cell number but also restores cNK cell development and maturation. Alcohol consumption does not significantly affect ILC1s.
MATERIALS AND METHODS

Experimental animals and alcohol administration
Female C57BL/6 mice at 6-7 wk old were purchased from Charles River Laboratories (Wilmington, MA, USA). Mice were housed in plastic cages with microfilter tops in the Washington State University (Spokane, WA, USA) Pharmaceutical and Biomedical Sciences building vivarium, which is fully accredited by the AAALAC International (Frederick, MD, USA). Mice were allowed free access to Purina Laboratory Rodent Diet 5001 (Nestlé Purina PetCare Company, St. Louis, MO, USA) and sterilized Milli-Q water (EMD Millipore, Billerica, MA, USA). After 1 wk of acclimation, mice were randomly divided into 2 groups. One group of mice was provided with Laboratory Rodent Diet and 20% w/v alcohol diluted from 190 proof alcohol (Everclear; Luxco, St. Louis, MO, USA) with Milli-Q water and sterilized by passing through 0.45-mm Millipore filter. The other group was the control and was continuously provided with Laboratory Rodent Diet and sterilized Milli-Q water. Mice receiving alcohol were fed 20% w/v alcohol for 3 mo before they were used for further experiments. That period mimics human alcoholism, and the immune parameters induced by chronic alcohol consumption are relatively stable [25, 27] . All animal protocols used in the present studies were approved by the Institutional Animal Care and Use Committee at Washington State University.
Antibodies and reagents
The following PE-, FITC-, PE-Cy5.5-, PerCP-Cy5.5-, PE-eFluor 610-, PE-eFluor 710-, PE-Cy7-, and APC-labeled anti-mouse mAbs were purchased from eBioscience (San Diego, CA, USA, now Affymetrix, part of Thermo Fisher Scientific): anti-CD3 (145-2C11), anti-CD11b (M1/70), anti-CD127 (A7R34), anti-Trail (N2B2), anti-Eomes (Dna11mag), anti-KLRG1 (2F1), anti-NK1.1 (PK136), anti-Granzyme B (NGZB), anti-T-bet (eBio4B10), anti-Ly49H (3D10), and anti-IFN-g (XMG1.2). The following PE-, FITC-, or PerCPlabeled anti-mouse mAbs were purchased from BioLegend (San Diego, CA, USA): anti-Ly49D (4E5), anti-Ly49C/I, anti-CD16/32 (clone 93), and anti-CD27 (LG.3A10). PMA and ionomycin were purchased from Sigma-Aldrich (St. Louis, MO, USA). The Foxp3/transcription factor staining-buffer set and intracellular fixation/permeabilization buffer were purchased from eBioscience. Lymphocyte isolation. Lymphocytes from spleen, peripheral blood, liver, BM, LNs (inguinal), and MLNs were isolated following previously reported methods [28] . The following protocol was used to isolate lymphocytes from lung. The lung was rinsed with 5 ml of ice-cold PBS and placed into a petri dish with 10 ml PBS + 0.1% BSA. Single-cell suspension was created by forcing the lung through a stainless wire screen with a syringe plunger. Cell debris was removed by passing the cell suspension through a BD Falcon (BD Biosciences, Franklin Lakes, NJ, USA) 100-ml cell strainer to a 50-ml conical tube and washing the cells with 50 ml of ice-cold PBS + BSA by centrifugation. The cells were resuspended into 5 ml of warm PBS + BSA, layered on top of 5 ml of Lympholyte-M (Cedarlane, Burlington, NC, USA) in a 15-ml conical tube, and centrifuged at room temperature, 800 g for 20-min. Lymphocytes were collected from the interface and transferred into a 15-ml conical tube. The cells were washed with 10 ml of ice-cold PBS + BSA. Cell number and viability were determined with a Beckman CELL XR cell viability analyzer (Beckman Coulter, Brea, CA, USA). Cells were resuspended into PBS + BSA at 10 8 cells/ml.
Flow cytometry analysis. For cell surface staining, lymphocytes were mixed with anti-mouse CD16/32 mAbs on ice for 5 min to block Fc receptors. Then, cells were mixed with Ab cocktail containing mAbs against specific cell-surface markers and incubated on ice for 30 min in the dark. Cells were washed with FACS buffer twice and analyzed with a Gallios flow cytometer and Kaluza software (Beckman Coulter). For intranuclear staining of transcription factors, cell surface markers were first stained following the cell surface staining protocol described above. After washing, the cells were fixed with Foxp3 transcription factor fixation/permeabilization buffer (eBioscience) for 20 min on ice in the dark. Cells were washed with washing buffer twice and incubated with anti-transcription factor mAbs on ice for 30 min in the dark. Cells were again washed with washing buffer twice and, then, analyzed with a Gallios flow cytometer and Kaluza software.
Lymphocyte activation and cytokine intracellular staining. Freshly isolated lymphocytes were cultured in RPMI 1640 medium supplemented with 10% FBS, and 1% penicillin and streptomycin in a 24-well plate with 2 3 10 6 cells/ml. PMA and ionomycin were added to the culture medium to stimulate the cells at the final concentration of 50 ng/ml and 500 ng/ml, respectively. Brefeldin A was used to block protein secretions at a final concentration of 5 mg/ml. Cells treated with Brefeldin A only, without PMA + ionomycin, were used as controls. Cells were incubated in a 5% CO 2 incubator at 37°C for 4 h. After stimulation, cells were harvested and washed with PBS + BSA. Cell surface staining was performed to stain CD3 and NK1.1 cells. Intracellular and intranuclear staining was conducted to stain T-bet, Eomes, IFN-g, and granzyme B, using the Foxp3 transcription factor fixation/permeabilization buffer, as described above. IFN-g-and granzyme B-producing cells were analyzed with a Gallios flow cytometer and Kaluza software. Statistical analysis. Microsoft (Redmond, WA, USA) Excel and Prism (GraphPad Software, La Jolla, CA, USA) were used to analyze the data. MannWhitney nonparametric 2-tailed test was used to determine the significance of the difference between water-drinking and alcohol-consuming mice. The difference between the 2 groups was considered significant at P , 0.05.
RESULTS
Chronic alcohol consumption decreases Eomes
+ cNK cells but not Eomes 2 ILC1s. We have previously found [24, 25] Chronic alcohol consumption compromises cNK cell maturation. We previously reported [25] (Fig. 3) . Lung and splenic ILC1s expressed Ly49 receptors, but the percentage was much lower compared with the cNK cells in the same organ (Fig. 3C) . Alcohol consumption did Experiments were repeated at least once with similar results. Water, water-drinking mice; EtOH, alcohol-consuming mice. *P , 0.05, **P , 0.01, ***P , 0.001.
not significantly affect Ly49 expression in ILC1s, except it decreased the percentage of Ly49H and Ly49D in splenic ILC1s (Fig. 3C ). Chronic alcohol consumption decreased the number of all subsets of Ly49 + cNK cells in the peripheral organs (Fig.  3D) . Only the percentage of Ly49H + cNK cells in total cNK cells decreased in all organs, whereas the percentage of the other subset of Ly49 + NK cells did not change (Fig. 3B) . These results indicate chronic alcohol consumption inhibits the acquisition of the Ly49 receptor, especially the activating receptor Ly49H in cNK cells.
Chronic alcohol consumption decreases KLRG1 + terminally differentiated cNK cells. KLRG1 is a terminal differentiation marker of NK cells [30] . If chronic alcohol consumption inhibits cNK cell development and maturation, it should also inhibit cNK cell terminal differentiation. Indeed, results indicated that chronic alcohol consumption significantly decreased the percentage and number of KLRG1 + terminally differentiated cNK cells (Fig. 4) Chronic alcohol consumption decreases granzyme B-producing cNK cells. The hallmark of mature cNK cell is the production of cytokine IFN-g and effector molecules, such as perforin and granzymes. We next determined whether chronic alcohol consumption affected the production of granzyme B and IFN-g. Results indicated that chronic alcohol consumption significantly decreased splenic granzyme B-producing cNK cells but increased the percentage of IFN-g-producing NK cells (Fig. 5) .
IL-15/IL-15Ra treatment recovers NK cell number and induces hyperresponsive NK cell proliferation in alcoholconsuming mice. We previously found [26] that chronic alcohol consumption leads to a decrease of splenic IL-15-producing cells, especially splenic CD11c hi IL-15-producing cells, which, in Experiments were repeated at least once with similar results. Water, water-drinking mice; EtOH, alcohol-consuming mice. *P , 0.05, **P , 0.01, ***P , 0.001.
turn, enhances NK cell apoptosis in spleen. Exogenous IL-15/IL15Ra treatment can recover NK cell numbers in chronic alcoholconsuming mice [26] . Here, we further determined how IL-15/ IL-15Ra treatment affects cNK and ILC1s in mice after chronic alcohol consumption. Consistent with our previous finding, IL-15/IL-15Ra treatment increased CD3 2 NK1.1 + cells in spleen, liver, and BM in both water-drinking and alcohol-consuming mice ( Fig. 6A and D) . We also found that IL-15/IL-15Ra treatment dramatically increased the percentage and number of cNK cells and ILC1s in the spleen and liver. Only cNK cells, but not ILC1s, were increased in the BM of both groups of mice (Fig.  6B , C, E, and F) ( Table 1) . Three days after IL-15/IL-15Ra treatment, the number of cNK cells in the spleen increased 13-fold and 36-fold in water-drinking mice and alcohol-consuming mice, respectively, compared with their untreated counterparts (Table 1) . Similarly, the number of liver cNK cells increased 75-fold and 174-fold, BM cNK cells increased 4-fold and 5-fold in water-drinking mice and alcohol-consuming mice, respectively (Table 1) . After IL-15/IL-15Ra treatment, the percentage and number of cNK cells in the spleen were significantly higher in alcohol-consuming mice than they were in water-drinking mice ( Fig. 6B and E) . There was no difference in the number and percentage of liver cNK cells between the 2 groups of mice ( Fig.  6B and E) . The IL-15Ra in ALT-803 is a fusion protein that contains human IgG1 Fc. To rule out the possibility that the increase of cNK and ILC1 in spleen and liver, especially the hyperresponsiveness of cNK cells in the spleen, of alcoholconsuming mice was induced by the activation of NK cell FcR signaling pathway, we used the same dose of recombinant human IgG1 Fc as a control to treat the control mice. Results indicated that human IgG1 Fc treatment cannot recover cNK cells in spleen and liver. The numbers of NK and cNK cells in spleen and liver and ILC1 cells in spleen were significantly lower in alcohol-consuming mice than they were in waterdrinking mice (Fig. 6G-I ). These results indicate that chronic alcohol consumption induces a hyperresponse of cNKs and ILC1s to IL-15/IL-15Ra stimulation in the spleen and liver but not in the BM. IL-15/IL-15Ra treatment restores and enhances cNK cell maturation in alcohol-consuming mice. We next determined the response of cNK cells in the spleen, liver, and BM at different developmental stages to treatment with IL-15/IL-15Ra in waterdrinking mice and alcohol-consuming mice. IL-15/IL-15Ra treatment increased the percentage and number of all subsets of cNK cells in all the examined organs of the 2 groups of mice ( Fig.  7 and Table 1 ). The degree of increase was more pronounced in the liver than it was in spleen and BM (Table 1) . For waterdrinking mice, the CD27 + CD11b 2 and CD27 + CD11b + cNK cells exhibited greater response than did the CD27 2 CD11b + mature cNK cells in spleen ( Table 1 ). The same trend was observed in the liver of alcohol-consuming mice. However, the CD27 Table 1 ). The degree of increase in the number of the 3 subsets of cNK cells in alcohol-consuming mice was significantly greater than it was in their water-drinking counterparts ( Table 1 ). The general outcome was that the number of CD27 + CD11b + and CD27 2 CD11b + cNK cells in the spleen of alcohol-consuming mice was significantly greater than in the spleen of water-drinking mice (Fig.7D) . There was no difference in the number of different developmental stages in cNK cells in the liver and BM (Fig. 7E and F) . Human IgG1 Fc treatment cannot recover CD27 2 CD11b + cNK cells in the spleen, liver, and BM. The number of CD27 2 CD11b + cNK cells in the spleen, liver, and BM of human IgG1 Fc-treated, alcohol-consuming mice was significantly lower than it was in the water-drinking controls (Fig. 7G-I ). These results indicated that IL-15/IL-15Ra treatment restores and enhances cNK cell maturation in the alcohol-consuming mice.
IL-15/IL-15Ra treatment increases Ly49 + cNK cells in the spleen and Ly49 + ILC1s in the spleen and BM of alcoholconsuming mice. We next determined whether IL-15/IL-15Ra treatment induced recovery of Ly49 + cNK cells and ILC1s in spleen and BM. Results indicated that, although the percentage of Ly49H + , Ly49D + , and Ly49F + cNK cells in the total cNK cells was still lower in the spleen of alcohol-consuming mince compared with their water-drinking counterparts (Fig. 8) , the number of Ly49H + and Ly49F + cNK cells in the spleen of alcoholconsuming mice was same as the number of these cells in the spleen of water-drinking mice, whereas the number of Ly49D + and Ly49G2 + cNK cells in the spleen of alcohol-consuming mice was significantly greater than in their water-drinking counterparts (Fig. 8E) . There was no difference in the number of Ly49 + cNK cells in the BM between the 2 groups of mice after IL-15/IL15Ra treatment (Fig. 8G) , although the percentage of Ly49G2 + and Ly49F + cNK cells in the BM of alcohol-consuming mice was slightly less than it was in the water-drinking mice (Fig. 8C) . The number of Ly49 + ILC1s in the BM of alcohol-consuming mice was significantly higher than it was in the BM of water-drinking mice after IL-15/IL-15Ra treatment (Fig. 8H) . Human IgG1 Fc treatment cannot recover the number of Ly49-expressing cNK cells in the spleen of alcohol-consuming mice (Fig. 8I) . These results indicate that IL-15/IL-15Ra treatment increases Ly49 + cNK cells in the spleen and Ly49 + ILCs in the spleen and BM. IL-15/IL-15Ra treatment enhances the terminal differentiation of cNK cells in the spleen. We next determined whether IL-15/IL-15Ra treatment recovers cNK cell terminal differentiation in alcohol-consuming mice. KLRG1 was used as a cNK cell terminal differentiation marker. Results indicated that IL-15/IL15Ra treatment significantly increased the percentage and number of KLRG1 + cNK cells in the spleen of alcohol-consuming mice over those in the spleen of water-drinking mice (Fig. 9) . The ILC1 number, but not percentage, increased in the spleen of alcohol-consuming mice compared with the water-drinking mice (Fig. 9) . In the control experiments, human IgG1 Fc treatment did not recover the decreased number of NK, cNK, and ILC1 cells in the spleen of alcohol-consuming mice (Fig. 9C) . These results indicated that IL-15/IL-15Ra treatment enhances cNK cell terminal differentiation.
IL-15/IL-15Ra treatment enhances granzyme B-producing cNK cells in alcohol-consuming mice. IL-15/IL-15Ra treatment restores and even enhances cNK cell development, maturation, and terminal differentiation. We next determined whether IL-15/IL-15Ra treatment restores cNK cell granzyme B-producing function. We used PMA stimulation and intracellular staining to determine IFN-g-and granzyme B-producing cNK cells in the spleen. Results indicated that, after IL-15/IL-15Ra treatment, almost all cNK cells produced IFN-g. There was no difference in the percentage of IFNg-producing cells in the splenic cNK cells between the 2 groups of mice (Fig. 10B) . The alcohol-consuming mice had a higher percentage of granzyme B-producing cells in the splenic cNK cells than did their water-drinking counterparts (Fig. 10E) . In the control group, human IgG1 Fc treatment did not change the alcohol consumption-induced increase in the percentage of IFN-g-producing cNK cells (Fig. 10C ) and the decrease in granzyme B-producing cNK cells (Fig. 10F) . These results suggest that IL-15/IL-15Ra treatment not only recovers cNK cell maturation but also enhances cNK cell function in terms of granzyme B production.
DISCUSSION
It is well established that chronic alcohol consumption decreases peripheral NK cell number and cytotoxicity in human and experimental animals [20, 21, 24, 31] . We and others previously found [25, 29, 32] that chronic alcohol consumption impairs splenic NK cell development and maturation by increasing immature NK cells and decreasing mature NK cells. The impairment could result in the defect in peripheral NK cell number and cytolytic activity because, during maturation, the NK cell population expands and acquires its cytotoxic function [33, 34] . Therefore, understanding how chronic alcohol consumption affects NK cell development and maturation is the key to revealing the underlying mechanism of chronic alcohol impairment of NK cell number and function. In the present study, our results clearly demonstrated that alcohol consumptioninduced decrease in the portion of mature NK cells results from the defect of cNK cell development at the CD27 + CD11b + developmental stage but does not result from the alternation of the ILC1s. The ILC1s are cells that share phenotypic and functional similarity with immature cNK cells. Our results further indicated that the defect in NK cell number, development, and function in alcohol-consuming mice can be restored by exogenous IL-15/IL-15Ra treatment. This implies that the alcohol consumption-induced NK cell defect is not intrinsic but is caused by the extrinsic availability of IL-15 in the microenvironment.
ILC1s are a recently identified cell population in humans and mice [7, 14] . These cells exist mainly on the mucosa surface. ILC1s are also found in spleen and liver [35] . Although these cells have high phenotypic and functional similarities with immature cNK cells, the major difference between ILC1s and cNK cells is their dependence on Eomes and IL-15. The expression of Eomes and the availability of IL-15 are essential for the development and maintenance of cNK cells. Although ILC1s do not express Eomes [12] , IL-15 is dispensable for intraepithelial ILC1s [13] but may be essential for other population of ILC1s [12] . In the present study, our data demonstrate that the defect in the availability of IL-15 leads to a decrease in cNK cell number and a defect in cNK cell development and maturation. However, the effects of alcohol consumption on ILC1s are minimal. This suggests that the demanding threshold of ILC1s to IL-15 may be less than the demanding threshold of cNK cells for IL-15. Alternatively, other cytokines, such as IL-7, may compensate for the IL-15 needs of ILC1s because some ILC1s express CD127, the IL-7 receptor a chain. ILC1s rigorously respond to IL-15 stimulation and exhibit robust proliferation in spleen and liver ( Fig. 6 and Table 1) .
Alcohol consumption decreases the number of peripheral cNK cells. The decreased cNK cells are a CD27
2 CD11b + population (Fig. 2) . The number of CD27 + CD11b + cells do not change;
however, the percentage of CD27 + CD11b + cNK cells in the total cNK cell population increase. This suggests that alcohol consumption impairs NK cell development at the late-maturation stage. Indeed, consistent with those results, we found that chronic alcohol consumption decreases terminal differentiated, KLRG1 + cNK cells in all examined organs (Fig. 4) .
NK cell development, differentiation, and maturation are regulated by many signaling pathways and factors, such as caloric intake and transcriptional regulation [36] [37] [38] . Calorie restriction impairs NK cell development and maturation, similar to what we found in the alcohol-consuming mice [38] . IL-15 is the cytokine that has the key role in regulating NK cell survival, development, proliferation, and activation [39] [40] [41] [42] . Low levels of IL-15 can maintain NK cell survival through activating the STAT5 signaling pathway [43] . High levels of IL-15 not only activate the Jak3/STAT5 signaling pathway for NK cell survival but also activate the mTOR signaling pathway. The mTOR signaling pathway, in turn, is critical for NK cell proliferation and cytotoxicity [43, 44] . Experiments were repeated at least once with similar results. Water, water-drinking mice; EtOH, alcohol-consuming mice. *P , 0.05, **P , 0.01, ***P , 0.001. not affect, or even increases, IFN-g production. These features are similar as the features found in the mTOR-depleted NK cells [43] . If the lack of the availability of IL-15 is the cause of impaired NK cell maturation and the decrease in NK cell number, then the treatment of exogenous IL-15 will not only rescue NK cell development and maturation but also restore and even increase total NK cell numbers. This is because alcohol consumption arrests NK cell at the less-mature stage. These NK cells are more hyperresponsive to IL-15 for proliferation than mature NK cells are. Consistent with that expectation, exogenous IL-15/IL-15Ra treatment fully recovered NK cell maturation (Fig. 7) , terminal differentiation (Fig. 9) , and granzyme B-producing function (Fig. 10) . Importantly, after IL-15/IL-15Ra treatment, the number of splenic NK cells in the alcohol-consuming mice was much greater than it was in the water-drinking mice (Fig. 6) , and the increased NK cells were CD27 + CD11b + and CD27 2 CD11b + mature NK cells (Fig. 7) . Consistent with an increase of mature cNK cells, the percentage of granzyme B-producing cells in the splenic cNK cells in alcohol-consuming mice was Experiments were repeated at least once with similar results. Water, water-drinking mice; EtOH, alcohol-consuming mice. *P , 0.05, **P , 0.01, ***P , 0.001. significantly greater than it was in their water-drinking counterparts (Fig. 10) . IL-15/IL-15Ra treatment also fully restored, even significantly increased, the number of Ly49-expressing NK cells. However, the percentages of Ly49H + and Ly49D + NK cells were still lower in the alcohol-consuming mice than they were in the waterdrinking mice (Fig. 8) . This is because IL-15 can only induce existing Ly49 + NK cell proliferation, but cannot induce Ly49 expression in Ly49 2 NK cells [45] .
IL-15 is the cytokine that not only plays the key role in NK cell development and maturation, but also governs the proliferation and survival of CD8 + memory T cells [47] . If the defect of NK cell development and maturation results from the lack of availability of IL-15 in the microenvironment in alcohol-consuming mice, then a defect in CD8 + memory T cells should be expected in these mice. Our previous and recent research has confirmed this expectation. We previously found that in steady-state chronic alcohol consumption increases the portion of CD8 + T cells with memory phenotype via enhancing homeostatic proliferation [48] . Accelerated turnover of CD8 + cells is a major driver in enhancing CD8 + T cell homeostatic proliferation in alcoholconsuming mice [48] . In the melanoma-bearing mice, chronic alcohol consumption inhibits CD8 + memory T cell, especially tumor-specific memory, CD8 + T cell expansion [49] . IL-15/IL15Ra (ATL-803) treatment can effectively restore CD8 + memory T cells in the alcohol-consuming and melanoma-bearing mice [50] . These results further support the notion that chronic alcohol consumption induces the IL-15 defect in the microenvironment.
The present research clearly indicated that alcohol consumption-induced NK dysfunction is extrinsic, and NK cell function can be restored by IL-15/IL-15Ra treatment. IL-15 treatment has exhibited promising therapeutic effect in different types of cancer immunotherapy in animal models and has also been tested in human clinical trials [51] [52] [53] . However, immunotolerance and immunotoxicity induced by IL-15 treatment greatly hamper the application of this approach [54] . For human alcoholics, IL-15 treatment could be an option for a short-term boost of NK cell function. For long-term recovery of NK cell function, it is necessary to recover the IL-15 production in the accessory cells. Different types of cells can produce IL-15 to govern the NK cell development at different developmental stages [55] [56] [57] .
In summary, the present study revealed that chronic alcohol consumption does not significantly affect ILC1 in the steady state. Alcohol consumption impairs cNK cell number and cytolytic activity by arresting cNK cell development at the CD27 + CD11b + stage. This developmental arrest of NK cells results from a defect in the availability of IL-15. Exogenous IL-15/IL-15Ra treatment can not only fully rescue NK cell development and maturation but also induce the NK cell hyperresponsiveness of proliferation. This suggests that the alcohol consumption-induced NK cell defect is extrinsic but not intrinsic. Therefore, recovering the availability of the microenvironmental IL-15 is the key to restoring NK cell function in alcoholics. 
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